Big Pharma’s Q2 growth, ranked: Regeneron, Pfizer lead the way as sales rebound from pandemic depthsnews2021-08-11T14:37:18+00:00August 11th, 2021|Fierce Pharma|
Surprise, surprise: AstraZeneca and FibroGen’s once-hyped anemia drug roxadustat hits an FDA wallnews2021-08-11T14:11:15+00:00August 11th, 2021|Fierce Pharma|
Vectura to choose next owner after Carlyle, Philip Morris submit final bids: reportnews2021-08-11T13:34:26+00:00August 11th, 2021|Fierce Pharma|
Perfect packaging? J&J’s latest innovation challenge crowdsources single dose ideasnews2021-08-10T20:14:32+00:00August 10th, 2021|Fierce Pharma|
Teva, Glenmark accuse U.S. government of improperly expanding price-fixing casenews2021-08-10T15:30:53+00:00August 10th, 2021|Fierce Pharma|
Novartis, Pfizer and Gilead roll out COVID-19 vaccination rules as Delta makes case for mandatesnews2021-08-10T15:29:15+00:00August 10th, 2021|Fierce Pharma|
UPDATED: Novartis, Pfizer and Gilead roll out COVID-19 vaccination rules as delta makes case for mandatesnews2021-08-10T15:29:15+00:00August 10th, 2021|Fierce Pharma|
Merck, Novo, Sanofi and more pull off China growth thanks to price maneuvering. But anxiety grows over outlook for biologicsnews2021-08-10T14:57:53+00:00August 10th, 2021|Fierce Pharma|
J&J matches Stelara’s ‘Bold’ message to the Olympic spirit in TV media buy during Tokyo gamesnews2021-08-10T14:56:45+00:00August 10th, 2021|Fierce Pharma|
Inflammasome gets Gates grant for dual HIV-birth control implantnews2021-08-10T13:32:19+00:00August 10th, 2021|Fierce Pharma|
